Nuwellis Inc. (NUWE)
NASDAQ: NUWE
· Real-Time Price · USD
1.07
0.08 (8.08%)
At close: May 01, 2025, 3:19 PM
8.08% (1D)
| Bid | 1.03 |
| Market Cap | 4.69M |
| Revenue (ttm) | 8.74M |
| Net Income (ttm) | -10.62M |
| EPS (ttm) | -8.41 |
| PE Ratio (ttm) | -0.13 |
| Forward PE | -1.96 |
| Analyst | Buy |
| Ask | 1.08 |
| Volume | 71,416 |
| Avg. Volume (20D) | 117,968 |
| Open | 1.02 |
| Previous Close | 0.99 |
| Day's Range | 1.02 - 1.08 |
| 52-Week Range | 0.75 - 12.60 |
| Beta | 0.51 |
About NUWE
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products ...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 2012
Employees 38
Stock Exchange NASDAQ
Ticker Symbol NUWE
Website https://www.nuwellis.com
Analyst Forecast
According to 1 analyst ratings, the average rating for NUWE stock is "Buy." The 12-month stock price forecast is $17, which is an increase of 1485.97% from the latest price.
Stock ForecastsNext Earnings Release
Nuwellis Inc. is scheduled to release its earnings on May 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+7.24%
Nuwellis shares are trading higher after the compa...
Unlock content with
Pro Subscription
4 months ago
-17.86%
Nuwellis shares are trading lower after the company announced it is voluntarily recalling specific lots of AquaFlexFlow UF 500 Plus extracorporeal blood circuit.
